Marinus Pharmaceuticals, Inc. earnings per share and revenue

MRNS earnings per share for the last quarter are -0.63 USD whereas the estimation was -0.59 USD which accounts for -6.71% surprise. Company revenue for the same period amounts to 8.06 M USD despite the estimated figure of 9.58 M USD. Estimated earnings per share for the next quarter are -0.41 USD, and revenue is expected to reach 9.42 M USD. Also watch annual changes over time to get a bigger picture of MRNS earnings per share and revenue dynamics.